Picture of Evotec SE logo

EVT — Evotec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Evotec Announces Progress In Protein Degradation Collaboration With Bristol Myers Squibb

April 24 (Reuters) - Evotec SE EVTG.DE:

EQS-NEWS: EVOTEC ANNOUNCES SIGNIFICANT PROGRESS IN STRATEGIC PROTEIN DEGRADATION COLLABORATION WITH BRISTOL MYERS SQUIBB

EVOTEC SE - TO RECEIVE $75 MILLION IN PAYMENTS

EVOTEC SE - COLLABORATION AIMS TO IDENTIFY NOVEL MOLECULAR GLUE DEGRADERS

Source text: ID:nEQ7PJVmja

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Evotec SE

See all news